Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Besides cholesterol lowering, statins boost antigen presentation and adaptive immune responses, suggesting new uses as adjuvants for cancer immunotherapy.
This study supports the suspected autoimmune nature of narcolepsy by showing that patients have memory T cells targeting self-antigens expressed by hypocretin neurons.
Laura Mackay describes two landmark papers by Gebhardt et al. and Masopust et al., published in 2009 and 2010, that signified the advent of tissue-resident memory T cells as a distinct T cell subset.
Naive CD4+ T cells are prepared for rapid activation and metabolic remodelling through the derepression of a poised translational machinery, which occurs independently of nutrient-sensing pathways.
A regulatory B cell subset has been identified that is characterized by the expression of LAG3. In response to TLR stimulation, these LAG3+ B cells produce IL-10.
Adrian Liston describes two papers by Nicole Le Douarin and colleagues from the 1980s that used a chick–quail graft system to show the existence of dominant T cell tolerance.
Macrophage priming by inflammatory stimuli drives the new synthesis and oxidation of mitochondrial DNA, which is essential for NLRP3 inflammasome activation.
Two papers published in Nature introduce a new subset of medullary thymic epithelial cells with properties similar to intestinal tuft cells, including IL-25 production and chemosensing ability.
Jeffrey Bluestone describes a 1987 study of anergic T cells by Marc Jenkins and Ron Schwartz that altered his thoughts about T cell tolerance and eventually gave birth to the field of checkpoint inhibition.